|
|
|
Insider
Information: |
Dorsey Brian |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
209,341 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$38,078 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
209,341 |
|
|
Total
Value |
$38,078 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
SVP, Technical Operati... |
2013-03-06 |
0 |
2007-04-25 |
0 |
Premium* |
|
Pernix Therapeutics Holdings |
PTX |
SVP Research |
2014-10-10 |
87,426 |
2013-04-19 |
0 |
Premium* |
|
Seelos Therapeutics Inc |
SEEL |
Former SVP, Chief Dev ... |
2018-08-30 |
115,891 |
2014-12-29 |
0 |
Premium* |
|
Silverback Therapeutics, Inc. |
SBTX |
|
2024-08-20 |
6,024 |
2024-08-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SBTX |
Silverback Therapeutics, ... |
Chief Operating Officer |
|
2024-08-20 |
4 |
OE |
$0.64 |
$32,000 |
D/D |
50,000 |
56,024 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Chief Development Officer |
|
2014-12-29 |
4 |
B |
$1.05 |
$10,481 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2009-12-31 |
4 |
AS |
$1.07 |
$5,345 |
D/D |
(5,000) |
49,712 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2010-02-05 |
4 |
OE |
$1.23 |
$13,530 |
D/D |
11,000 |
11,000 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2010-02-26 |
4 |
OE |
$1.23 |
$7,380 |
D/D |
6,000 |
6,000 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2010-03-01 |
4 |
OE |
$1.23 |
$28,290 |
D/D |
23,000 |
23,000 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2010-03-18 |
4 |
OE |
$1.23 |
$71,340 |
D/D |
58,000 |
67,420 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
|
2010-06-24 |
4 |
OE |
$1.23 |
$11,070 |
D/D |
9,000 |
3,795 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
|
2010-07-15 |
4 |
OE |
$1.23 |
$3,690 |
D/D |
3,000 |
54,920 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
|
2010-08-10 |
4 |
OE |
$1.23 |
$3,690 |
D/D |
3,000 |
54,920 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
|
2010-08-25 |
4 |
OE |
$1.23 |
$6,150 |
D/D |
5,000 |
56,920 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
|
2010-09-01 |
4 |
OE |
$1.23 |
$3,690 |
D/D |
3,000 |
54,920 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
|
2017-09-05 |
4 |
D |
$1.56 |
$21,985 |
D/D |
(14,093) |
164,601 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
|
2018-01-01 |
4 |
D |
$1.84 |
$10,092 |
D/D |
(5,485) |
159,116 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2007-04-25 |
4 |
OE |
$2.40 |
$9,600 |
D/D |
4,000 |
4,000 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2007-04-27 |
4 |
OE |
$2.40 |
$2,797 |
D/D |
1,000 |
661 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2007-05-31 |
4 |
OE |
$2.40 |
$4,396 |
D/D |
1,500 |
1,500 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
|
2010-12-01 |
4 |
AS |
$2.68 |
$22,727 |
D/D |
(8,468) |
43,452 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
|
2017-02-15 |
4 |
D |
$2.78 |
$4,156 |
D/D |
(1,495) |
103,694 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2010-02-05 |
4 |
AS |
$3.06 |
$63,368 |
D/D |
(20,712) |
0 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2010-03-18 |
4 |
D |
$3.94 |
$21,985 |
D/D |
(5,580) |
21,920 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2010-02-26 |
4 |
AS |
$3.99 |
$23,940 |
D/D |
(6,000) |
0 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
|
2010-07-15 |
4 |
AS |
$3.99 |
$11,970 |
D/D |
(3,000) |
51,920 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
|
2010-08-10 |
4 |
AS |
$3.99 |
$11,970 |
D/D |
(3,000) |
51,920 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
VP Product Development |
|
2010-03-01 |
4 |
AS |
$4.01 |
$92,179 |
D/D |
(23,000) |
0 |
0 |
- |
|
60 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|